PODCAST

Healio Minute

Healio

The latest health care news you need, when you need it. Only at Healio.

health & fitness medicine

All Episodes

13:59

Lung Cancer Edition: Top Headlines for Week of June...

Healio Minute ·

2025/06/26

In this edition, DREAM program ‘better than anything’ available, maintenance regimen a potential new standard and more. Read the full coverage here: DREAM program ‘better than anything’ available for patients with advanced lung cancer Maintenance regimen a potential new standard in extensive-stage small cell lung cancer ‘It can save their lives’: Annual lung cancer screening improves cancer detection rate Assay predicts adjuvant chemotherapy benefit in early-stage non-small cell lung cancer

13:41

Lung Cancer Edition: Top Headlines for Week of June...

Healio Minute ·

2025/06/02

In this edition, reduction efforts prevent 3.8 million lung cancer deaths since 1970, first-line combination should be ‘new standard’ in advanced lung cancer and more. Read the full coverage here: Smoking cessation, reduction efforts prevent 3.8 million lung cancer deaths since 1970 First-line combination should be ‘new standard’ in advanced lung cancer Only 1 in 5 people treated with immune checkpoint inhibitors respond to therapy ‘It can save their lives’: Annual lung cancer screening improves

13:59

Lung Cancer Edition: Top Headlines for Week of April...

Healio Minute ·

2025/04/29

12:01

Gastroenterology Edition: Top Headlines for Week of...

Healio Minute ·

2025/04/16

In this edition, sick food service workers top driver of viral foodborne outbreaks in US, no weight loss benefit with semaglutide before bariatric surgery and more. Read the full coverage here: Sick food service workers remain top driver of viral foodborne outbreaks in US ‘We have work to do’: No weight loss benefit with semaglutide before bariatric surgery Mailed FIT outreach program boosts colorectal cancer screening in rural areas ‘Distinct viral exposure patterns’ found in patients with

12:20

Lung Cancer Edition: Top Headlines for Week of March...

Healio Minute ·

2025/03/20

In this edition, recurrence-free survival estimates in less advanced lung cancer, bronchoscopy-guided microwave ablation safe in lung abnormality and more. Read the full coverage here: Recurrence-free survival estimates after surgery higher in less advanced lung cancer Electromagnetic navigation bronchoscopy-guided microwave ablation safe in lung abnormality High prevalence of atherosclerosis detected in patients entering lung cancer therapy Wood dust exposure negatively impacts lung function in

13:36

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2025/02/20

In this edition, robotic-assisted bronchoscopy a ‘game changer’, global mortality related to tobacco drops, particulate matter rises and more. Read the full coverage here: Robotic-assisted bronchoscopy a ‘game changer’ in early diagnosis of lung cancer Global lung cancer mortality related to tobacco drops, particulate matter rises in 2019 Osimertinib linked to more therapy-related cardiac events than other TKIs for NSCLC Survival better with lobectomy vs. wedge resection in early stage lung

11:23

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2025/01/23

In this edition, combination extends survival vs. standard first-line therapy, integrated care for smoking cessation during lung cancer screening and more. Read the full coverage here: Combination extends survival vs. standard first-line therapy for advanced lung cancer Integrated care ‘best treatment option’ for smoking cessation during lung cancer screening FDA proposes cap on nicotine levels in cigarettes Global lifetime risk for lung cancer in 2022 differs by human development index, sex

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/12/19

13:25

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/12/19

In this edition, we bring you Healio’s top lung cancer headlines in 2024. Read the full coverage here: California doctor with lung cancer receives first-of-its-kind lung-liver transplant ‘We were shocked’: Vaping considerably increases lung cancer risk among people who smoke FDA places hold on trial of cell therapy for lung cancer after patient death Findings highlight ‘desperate need’ to improve end-of-life cancer treatment ‘We have the technology’: Telehealth increases access to palliative

10:57

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/11/14

In this edition, single-fraction SBRT outcomes for central lung tumors, adjuvant durvalumab extends survival in limited-stage small cell lung cancer and more. Read the full coverage here: Single-fraction SBRT confers ‘surprisingly excellent’ outcomes for central lung tumors Adjuvant durvalumab extends survival in limited-stage small cell lung cancer Depression among people with head and neck cancers likely underreported, undertreated FDA approves tumor treating fields as part of combination

10:45

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/10/17

In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more. Read the full coverage here: FDA approves Rybrevant for advanced lung cancer Lung cancer screening orders in eligible patients higher with digital health program FDA approves Opdivo regimen for resectable NSCLC Study quantifies survival benefit of immunotherapy in metastatic NSCLC FDA expands osimertinib approval for advanced non-small cell lung

11:48

Rheumatology/Psoriatic Arthritis Edition: Top...

Healio Minute ·

2024/09/26

In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis, infliximab biosimilar increase after release of a third option and more. Read the full coverage here: Blue-collar workers more likely to miss work, quit due to psoriatic arthritis Infliximab biosimilar uptake rapidly increased only after release of a third option National Psoriasis Foundation to honor leaders at 2025 Commit to Cure Gala Safety checklist compiles clinically important DMARD warnings

13:55

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/09/19

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more. Read the full coverage here: FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’ Perioperative nivolumab improves outcomes in resectable NSCLC Despite progress, barriers to lung cancer biomarker testing persist Atezolizumab regimen ‘merits further study’ for unresectable

Lung Cancer Edition: Top Headlines for Week of...

Healio Minute ·

2024/09/19

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, Ivonescimab ‘may be a new standard’ and more. Read the full coverage here: FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’ Perioperative nivolumab improves outcomes in resectable NSCLC Despite progress, barriers to lung cancer biomarker testing persist Atezolizumab regimen ‘merits further study’ for unresectable

08:40

DME/Retina Edition: Top Headlines for Week of...

Healio Minute ·

2024/09/12

In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here: Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema OCT, visual acuity popular benchmarks in clinical practice guidelines for DME First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema OCS-01 eye drop for DME in second stage of phase 3 trial Q&A: Susvimo delivers

11:18

Rheumatology/Psoriatic Arthritis Edition: Top...

Healio Minute ·

2024/08/22

In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more. Read the full coverage here: Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease Inhibitor class PsO treatments exhibit similar efficacy in mitigating PsA risk S100 protein levels predict abatacept response in juvenile idiopathic arthritis Izokibep shows early

15:14

Lung Cancer Edition: Top Headlines for Week of August...

Healio Minute ·

2024/08/15

In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more. Read the full coverage here: Low education level raises risk for loss to follow-up in lung cancer screening program Lung cancer screening judgement strongly influenced by clinicians Occupational benzene exposure heightens lung cancer likelihood Chemotherapy plus nintedanib has ‘promising’ efficacy in small cell lung cancer with IPF Blood biomarker

11:23

DME/Retina Edition: Top Headlines for Week of August...

Healio Minute ·

2024/08/08

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more. Read the full coverage here: Sozinibercept combination therapy shows durability in patients with DME, neovascular AMD VIDEO: Comparable improvements seen with aflibercept 8 mg vs. 2 mg in DME DPP-IV, SGLT2 and GLP-1 drugs do not increase risk for diabetic macular edema Eluminex doses first patient in phase 1b trial of EB-105 for diabetic macular edema VIDEO: Port delivery

11:11

Rheumatology/Psoriatic Arthritis Edition: Top...

Healio Minute ·

2024/07/25

In this edition, guselkumab brings ‘stringent’ control through 2 years, SARDs outpatient visits result in opioid prescriptions and more. Read the full coverage here: Guselkumab brings active psoriatic arthritis into ‘stringent’ control through 2 years Nearly one-quarter of all SARDs outpatient visits in US result in opioid prescription FDA approves biosimilar Pyzchiva for all approved Stelara indications Tofacitinib effective for juvenile idiopathic arthritis through 4 years Bimekizumab

12:40

Lung Cancer Edition: Top Headlines for Week of July...

Healio Minute ·

2024/07/18

In this edition, atezolizumab benefits PD-L1-selected patients with NSCLC, risks persist with e-cigarette use after quitting tobacco smoking and more. Read the full coverage here: Adjuvant atezolizumab benefits PD-L1-selected patients with NSCLC Lung cancer risks persist with e-cigarette use after quitting tobacco smoking COPD, IPF end of life health care use differs from lung cancer Tecentriq combination fails to improve survival in metastatic lung cancer Risk for lung cancer reoccurrence may

149 results

Healio Minute

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown